no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A Proposal to Improve Treatment of Patients with Gynecologic Cancer in Developing Countries
|
Hemida, Reda A. |
|
2009 |
2 |
1 |
p. 38-43 6 p. |
article |
2 |
CON: Patients with Recurrent Ovarian Carcinoma Should Not Be Treated with Antiangiogenic Agents in Combination with Chemotherapy
|
Sabbatini, Paul |
|
2009 |
2 |
1 |
p. 16-18 3 p. |
article |
3 |
CON: Secondary Surgical Debulking Is Not an Acceptable Option in Patients with Recurrent Platinum-Sensitive Ovarian Cancer
|
Thigpen, J. Tate |
|
2009 |
2 |
1 |
p. 21-23 3 p. |
article |
4 |
Getting Personal! The Treatment of Epithelial Ovarian Cancer
|
Farley, John |
|
2009 |
2 |
1 |
p. 9-11 3 p. |
article |
5 |
Is Serum Albumin an Independent Predictor of Survival in Ovarian Cancer?
|
Gupta, Digant |
|
2009 |
2 |
1 |
p. 52-56 5 p. |
article |
6 |
Is the Adjustment of Serum Creatinine Level from < 0.6 mg/dL to 0.6 mg/dL Justified in Estimating Carboplatin Clearance Calculated by the Jelliffe Formula?
|
Nagao, Shoji |
|
2009 |
2 |
1 |
p. 48-51 4 p. |
article |
7 |
Ovarian Cancer in a Man?
|
Sumrall, Ashley |
|
2009 |
2 |
1 |
p. 57-59 3 p. |
article |
8 |
PRO: Patients with Recurrent Ovarian Cancer Should Be Treated with Antiangiogenic Agents in Combination with Chemotherapy
|
Boruta, David |
|
2009 |
2 |
1 |
p. 12-15 4 p. |
article |
9 |
PRO: Secondary Surgical Debulking Is an Acceptable Option in Patients with Recurrent Platinum-Sensitive Ovarian Cancer
|
Nagel, Christa I. |
|
2009 |
2 |
1 |
p. 19-20 2 p. |
article |
10 |
Safety of Bevacizumab in Advanced Ovarian and Müllerian Cancers: A Review
|
Campos, Susana M. |
|
2009 |
2 |
1 |
p. 31-37 7 p. |
article |
11 |
Trial Design Strategies for Vascular-Targeted Therapy of Patients with Ovarian Cancer
|
Varughese, Mohini A. |
|
2009 |
2 |
1 |
p. 24-30 7 p. |
article |
12 |
Use of Docetaxel After Paclitaxel Hypersensitivity Reaction in Epithelial Ovarian and Endometrial Cancer
|
Isonishi, Seiji |
|
2009 |
2 |
1 |
p. 44-47 4 p. |
article |